Reyataz, which will help simplify HIV drug regimens
January 2004
Bristol-Myers Squibb is now marketing Reyataz, which will help simplify HIV drug regimens.
Reyataz (atazanavir) is a protease inhibitor. It's given just ONCE per day.
Reyataz doesn't increase cholesterol or triglycerides.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive